Full-Time

Internal Audit Associate

Confirmed live in the last 24 hours

Veracyte

Veracyte

501-1,000 employees

Develops genomic tests for cancer diagnosis

Biotechnology
Healthcare

Compensation Overview

$28.5 - $36Hourly

+ Bonus + Incentives + Restricted Stock Units

Entry, Junior

Remote in USA

Category
Auditing
Accounting
Required Skills
Data Analysis
Requirements
  • Bachelor’s degree in Accounting, Finance, or a related field
  • 2 years in Public Accounting, Internal Auditing, Internal Control Design/Documentation or testing, or a comparable position within a Corporate Finance function
  • Experience with one of the Big Four accounting firms is a plus
  • Knowledge of internal audit functions, including the ability to apply auditing (GAAS), accounting (GAAP) and or industry standards to operational/financial/compliance audits
  • Understanding of internal control concepts and frameworks (COSO, COBIT) and prior experience testing key controls
  • Effective written and oral communication skills with the ability to establish and maintain business relationships and develop solutions, emphasizing a client-based focus to understand and respond appropriately to business requirements
  • Working knowledge of any data analytics tools and audit management software is a plus
Responsibilities
  • Under the direction of the Internal Audit management, you will lead and participate in Financial, Operational, and SOX audit assignments for Veracyte’s domestic and international subsidiaries.
  • Conduct process walkthroughs to evaluate design and perform key controls testing to determine effectiveness of internal controls.
  • Support development of presentations to discuss internal audit and SOX compliance audit results with management.
  • Effectively perform audit assignments from planning through reporting, focusing on continuous improvement and results with a sense of urgency.
  • Utilize data analytics tools for all phases of the audit lifecycle.
  • Assist in the development of the annual internal audit plan using a risk-based approach.
  • Prepare detailed audit reports on the effectiveness of the internal control structure for an executive level audience with observations, recommendations and actions plans to address identified issues. Ensure reported findings are appropriately documented and supported by evidence and present results to management.
  • Build positive relationships across the organization at all levels to effectively deliver audit solutions and contribute directly to business success.

Veracyte specializes in cancer diagnostics by developing advanced genomic tests that assist in the early detection and diagnosis of various cancers. Their tests analyze genetic information from non-invasive samples, such as nasal swabs or tissue biopsies, providing crucial insights into the presence and progression of cancer. This allows healthcare providers, including hospitals and clinics, to make informed treatment decisions tailored to individual patients. Veracyte differentiates itself from competitors by focusing on non-invasive testing methods and continuously investing in research to expand its product offerings. The company's goal is to improve patient outcomes and enhance the efficiency of cancer treatment through accurate and early diagnosis.

Company Stage

IPO

Total Funding

$69.4M

Headquarters

San Francisco, California

Founded

N/A

Growth & Insights
Headcount

6 month growth

5%

1 year growth

7%

2 year growth

10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Recognition as a Bay Area Top Workplace for 11 consecutive years highlights a positive work environment and strong company culture.
  • Significant investments from firms like Aigen Investment Management and Quest Partners indicate strong financial backing and growth potential.
  • The upcoming launch of ClearLab and an MRD assay in 2026 showcases Veracyte's commitment to expanding its product portfolio and market reach.

What critics are saying

  • The competitive landscape in genomic diagnostics is intense, requiring Veracyte to continuously innovate to maintain its market position.
  • Dependence on successful clinical validation and regulatory approval for new tests can pose risks to product launch timelines.

What makes Veracyte unique

  • Veracyte specializes in non-invasive genomic tests for early cancer detection, setting it apart from traditional diagnostic methods.
  • Their Decipher Prostate and Bladder Genomic Classifiers offer superior prognostic information compared to standard approaches, enhancing treatment personalization.
  • Continuous investment in R&D and clinical validation ensures that Veracyte's tests remain at the forefront of cancer diagnostics.

Help us improve and share your feedback! Did you find this helpful?